Article
An Engineered T7 RNA Polymerase for efficient co-transcriptional capping with reduced dsRNA byproducts in mRNA synthesis
2022-09-02
Abstract excerpt
Messenger RNA (mRNA) therapies have recently gained tremendous traction with the approval of mRNA vaccines for the prevention of SARS-CoV-2 infection. However, manufacturing challenges have complicated large scale mRNA production, which is necessary for the clinical viability of these therapies. Not only can the incorporation of the required 5’ 7-methylguanosine cap analog be inefficient and costly, in vitro trans...
Topics
Open a Topic to create a Post that cites this publication.
Identifiers and source
- Literature Corpus work
- 359fe187-dfd6-5208-9dbb-064657124380
- DOI
- 10.1101/2022.09.01.506264
